Lockheed Martin Corporation (LMTB34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 3,331.51 |
|---|---|
| 52-week range | 2,349.66 – 3,991.00 |
| Return, 1 month / 3 months | +24.0% / +12.3% |
| Return, 1 year / 3 years | +29.2% / +59.6% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 34.5% |
| Worst drawdown (1 year) | -29.5% |
| Average daily value traded | 0.12M BRL |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lockheed Martin Corporation is an American defence and aerospace company based in Bethesda, Maryland. It designs and builds military aircraft, including fighter jets, as well as helicopters, missiles, missile defence systems and space and cyber equipment. Its main customers are government defence and security agencies, chiefly in the United States, along with allied armed forces and some commercial and civil space customers. The company also provides maintenance, training and technical support services for the systems it supplies.
Lockheed Martin Corporation is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code LMTB34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lockheed Martin Corporation (LMTB34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 3,331.51 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 386 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.2% and over the last three months it rose 12.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 14.7% | ||
| From 52-week high | -5.4% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.3% | ||
| 6-month return | 30.7% | ||
| 12-month return, skipping the last month | 4.2% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.5% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.12M BRL | ||
| Zero-volume days | 5.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +20.5% |
|---|---|
| 1 month | +24.0% |
| 3 months | +12.3% |
| 6 months | +30.7% |
| 1 year | +29.2% |
| 3 years | +59.6% |
| 5 years | +97.6% |
Signals
| 50-day / 200-day average | 2,777.06 / 2,903.56 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 95.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | USD 11.8064 |
| 27 Feb 2026 | USD 11.9618 |
| 28 Nov 2025 | USD 12.5526 |
| 1 Sep 2025 | USD 11.6745 |
| 30 May 2025 | USD 11.9391 |
| 27 Feb 2025 | USD 12.5730 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.